Apellis Pharmaceuticals to Host Conference Call on Nov 7, 2022 to Discuss Third Quarter 2022 Financial Results

Rhea-AI Summary

Apellis Pharmaceuticals (APLS) has announced a conference call scheduled for November 7, 2022, at 4:30 p.m. ET to discuss its third quarter 2022 financial results. The live call will be accessible via phone and through a webcast available on the company's website. The firm is recognized for pioneering the first new class of complement medicine in 15 years, aiming to develop transformative therapies for rare, retinal, and neurological diseases. Further information on the event and the company can be found on their official website.

Positive

• Leading the complement medicine space with innovative therapies.
• Scheduled conference call to discuss Q3 2022 financial results, indicating transparency and engagement with investors.

Negative

• None.

WALTHAM, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will host a conference call and webcast to discuss its third quarter 2022 financial results on Monday, November 7, 2022 at 4:30 p.m. ET.

To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 30 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com 
617.599.8178

FAQ

When will Apellis Pharmaceuticals discuss its Q3 2022 financial results?

Apellis Pharmaceuticals will discuss its Q3 2022 financial results on November 7, 2022, at 4:30 p.m. ET.

How can I access the Apellis Pharmaceuticals conference call?

You can access the conference call by pre-registering for the call or by joining the live audio webcast available on their website.

What is Apellis Pharmaceuticals known for?

Apellis Pharmaceuticals is known for pioneering the first new class of complement medicine in 15 years, focusing on treatments for rare, retinal, and neurological diseases.

Where can I find more information about Apellis Pharmaceuticals?

More information can be found on Apellis Pharmaceuticals' official website.